16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25127101	26	Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists.	Dainippon Sumitomo Pharma
22708876	106	Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-ß-alanine (MK-0893) for the treatment of type II diabetes.	Merck Research Laboratories
11543679	15	A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning.	University of Arizona
10794689	10	Design and synthesis of conformationally constrained glucagon analogues.	University of Arizona
9258362	30	The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.	University of Arizona
8691441	19	Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.	University of Arizona
21147532	82	Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.	Merck Research Laboratories
	2	[des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonist	TBA
	1	CP-99,711: a non-peptide glucagon receptor antagonist	TBA
18707090	68	Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor.	Novo Nordisk
17201415	47	New beta-alanine derivatives are orally available glucagon receptor antagonists.	Novo Nordisk
12477359	78	Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide.	Novo Nordisk
11844695	35	Human glucagon receptor antagonists based on alkylidene hydrazides.	Pfizer
11543683	42	Identification of alkylidene hydrazides as glucagon receptor antagonists.	Pfizer
11311060	12	Development of potent truncated glucagon antagonists.	University of Arizona